Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 340.50
+10.50 (3.18%)
Oct 31, 2025, 1:35 PM CST
Pegavision Market Cap
Pegavision has a market cap or net worth of 26.56 billion as of October 31, 2025. Its market cap has decreased by -20.07% in one year.
Market Cap
26.56B
Enterprise Value
23.69B
Revenue
6.90B
Ranking
n/a
PE Ratio
16.71
Stock Price
340.50
Market Cap Chart
Since December 30, 2014, Pegavision's market cap has increased from 9.60B to 26.56B, an increase of 176.66%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 26.56B | -9.68% |
| Dec 31, 2024 | 29.41B | -4.92% |
| Dec 29, 2023 | 30.93B | 4.20% |
| Dec 30, 2022 | 29.68B | -0.70% |
| Dec 30, 2021 | 29.89B | 50.88% |
| Dec 31, 2020 | 19.81B | 55.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 181.96B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lotus Pharmaceutical | 75.87B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.27B |
| Polaris Group | 27.16B |
| Center Laboratories | 25.23B |